Sanofi diabetes drug Toujeo wins European green light
February 27, 2015 at 07:17 AM EST
LONDON, Feb 27 (Reuters) - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators said on Friday.